Tyrosine-protein phosphatase non-receptor type 11 (SHP2) plays an important role in CML since it is required to initiate and maintain BCR-ABL-mediated transformation, which is vital in leukemogenesis and hematopoiesis [27]). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.